4180020/2026 - AQ 2023/437 - Antiallergic medication, vitamins and mineral salts and medications used in poisoning

This tender, identified by the reference number 4180020/2026 and linked to framework agreement AQ 2023/437, concerns the procurement of specific pharmaceutical products. The focus is on antiallergic medications, vitamins, and mineral salts, as well as medications specifically used in the treatment of poisoning. This procurement aims to ensure the availability of these essential medical supplies, which cater to a range of health needs from allergic reactions and nutritional support to emergency treatment for toxic exposures. The reference to framework agreement AQ 2023/437 suggests that this is part of a larger, pre-established procurement mechanism designed to streamline the acquisition of these types of drugs. Bidders are expected to supply products that meet the quality standards and specifications outlined within the framework agreement, ensuring that healthcare providers have access to the necessary treatments for patients requiring them. The tender is crucial for maintaining adequate stock levels of these vital medications.

This is a supplies contract in the health and medical services, mining and extractives and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 998.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.